RespireRx Pharmaceuticals Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Return On Assets for the quarter ending September 30, 2023 was -1.95K %, a 17% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Return On Assets for 2022 was -3.31K %, a 80.5% decline from 2021.
  • RespireRx Pharmaceuticals Inc. annual Return On Assets for 2021 was -1.83K %, a 65.2% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Return On Assets for 2020 was -5.26K %, a 178% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -1.95K +400 +17% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.41K -591 -32.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -2.71K -865 -46.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.31K -1.47K -80.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.35K +86.9 +3.57% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.82K +2.49K +57.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.84K +3.21K +63.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.83K +3.43K +65.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.44K +2.95K +54.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -4.32K -929 -27.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -5.06K -2.55K -102% Jan 1, 2021 Mar 31, 2021
Q4 2020 -5.26K -3.37K -178% Oct 1, 2020 Dec 31, 2020
Q3 2020 -5.39K -3.74K -228% Jul 1, 2020 Sep 30, 2020
Q2 2020 -3.39K -1.96K -137% Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.51K -957 -61.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.89K -260 -15.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.64K -205 -14.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.43K +98.4 +6.43% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.55K +397 +20.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.63K +118 +6.75% Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.44K +561 +28.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.53K +1.12K +42.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.95K +306 +13.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.75K +1.46K +45.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -2K +1.59K +44.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -2.65K +83.4 +3.05% Apr 1, 2017 Jun 30, 2017
Q1 2017 -2.25K +843 +27.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -3.21K -1.35K -72.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -3.59K -2.29K -176% Jul 1, 2016 Sep 30, 2016
Q2 2016 -2.73K -1.6K -141% Apr 1, 2016 Jun 30, 2016
Q1 2016 -3.1K -2.45K -380% Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.86K -1.04K -127% Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.3K -458 -54.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -1.13K -417 -58.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -645 +557 +46.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -821 +930 +53.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -842 +3.9K +82.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -717 -63.9 -9.78% Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.2K -567 -89.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -1.75K -1.2K -219% Oct 1, 2013 Dec 31, 2013
Q3 2013 -4.74K -4.58K -2850% Jul 1, 2013 Sep 30, 2013
Q2 2013 -653 -433 -197% Apr 1, 2013 Jun 30, 2013
Q1 2013 -636 -511 -408% Jan 1, 2013 Mar 31, 2013
Q4 2012 -549 Oct 1, 2012 Dec 31, 2012
Q3 2012 -161 Jul 1, 2012 Sep 30, 2012
Q2 2012 -220 Apr 1, 2012 Jun 30, 2012
Q1 2012 -125 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.